Gefurulimab found to ease gMG symptoms in global Phase 3 trial
Gefurulimab outperformed a placebo in easing gMG symptoms in a clinical trial involving over 250 patients positive for anti-AChR antibodies.| Myasthenia Gravis News
Gefurulimab outperformed a placebo in easing gMG symptoms in a clinical trial involving over 250 patients positive for anti-AChR antibodies.| Myasthenia Gravis News
Is myasthenia gravis actually a rare disease? Columnist Shawna Barnes addresses this common question in the MG community.| Myasthenia Gravis News
Getting a correct myasthenia gravis diagnosis may require a series of blood, nerve, muscle, and imaging tests.| Myasthenia Gravis News
Living with myasthenia gravis can be challenging, but the right strategies can help you manage your symptoms and ease their effects.| Myasthenia Gravis News
Marisa Wexler is a senior science writer for Myasthenia Gravis News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of myasthenia gravis topics.| Myasthenia Gravis News
Category archive page for News.| Myasthenia Gravis News
Myasthenia gravis is a neuromuscular disease characterized by weakness and fatigue that can affect muscles involved in voluntary movements.| Myasthenia Gravis News
